Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Net Cash Flow (2016 - 2025)

Bioadaptives' Net Cash Flow history spans 7 years, with the latest figure at $99172.0 for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 5.98% to $99172.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$261025.0, a 685.28% decrease, with the full-year FY2025 number at $20975.0, down 72.65% from a year prior.
  • Net Cash Flow hit $99172.0 in Q4 2025 for Bioadaptives, up from -$151309.0 in the prior quarter.
  • Over the last five years, Net Cash Flow for BDPT hit a ceiling of $111951.0 in Q3 2023 and a floor of -$151309.0 in Q3 2025.
  • Historically, Net Cash Flow has averaged -$8011.9 across 5 years, with a median of -$7256.5 in 2021.
  • Biggest five-year swings in Net Cash Flow: soared 3057.68% in 2021 and later plummeted 1654.5% in 2023.
  • Tracing BDPT's Net Cash Flow over 5 years: stood at $16597.0 in 2021, then crashed by 64.61% to $5873.0 in 2022, then plummeted by 1654.5% to -$91296.0 in 2023, then skyrocketed by 202.5% to $93577.0 in 2024, then grew by 5.98% to $99172.0 in 2025.
  • Business Quant data shows Net Cash Flow for BDPT at $99172.0 in Q4 2025, -$151309.0 in Q3 2025, and -$110982.0 in Q2 2025.